What are the GW pharmaceuticals

JAZZ PHARMACEUTICALS PLC

BAYER55,99+0,48 %SHARE IN FOCUS: Bayer over the counter under pressure due to glyphosate setbackFRANKFURT (dpa-AFX) - Bayer investors have to cope with another setback in a second US appeal on Monday due to alleged cancer risks of the weed killer glyphosate ....
► Read articlePFIZER32,800-0,05 %Shares: Sanofi - now new vaccines are comingNOVARTIS72,49-0,23 %Novartis has delivered one billion malaria treatments since 1999This includes 430 million treatments for children. More than 90 percent of this artemisinin-based combination therapy (ACT) has been delivered to malaria-endemic countries for no profit ...
► Read articleNOVO NORDISK66,87+0,71 %JPMORGAN leaves NOVO NORDISK on 'Overweight'NEW YORK (dpa-AFX Analyzer) - The US bank JPMorgan has left the rating for Novo Nordisk at "Overweight" with a price target of 500 Danish kroner. The analyst Richard Vosser sees in a ...
► Read articleGILEAD SCIENCES56,45-0,48 %Nasdaq soon with new all-time highs? Gilead, Gamestop, Facebook in the checkYou can find more videos at: https://www.deraktionaer.tv The Nasdaq has recently taken a few steps backwards - maybe just to get started? Andreas Wolf takes a closer look at the potential ...
► Read articleAURORA CANNABIS6,204+3,56 %Cannabis Report: Aurora Cannabis (21P1) disappointed; Colorado reports very high demand(shareribs.com) Toronto 05/17/2021 - Canadian cannabis producer Aurora Cannabis recently released its results for the past quarter. Investors reacted disappointed. In the US state ...
► Read articleMERCK KGAA146,85+0,24 %DEUTSCHE BANK leaves MERCK KGAA on 'Buy'FRANKFURT (dpa-AFX Analyzer) - Deutsche Bank has raised the price target for Merck KGaA from 146 to 155 euros and left the rating at "Buy". Analyst Falko Friedrichs sees in a Monday ...
► Read articleSTADA MEDICINAL PRODUCTS103,00+0,98 %"Pharmacies are great partners": What Stada learned from the Corona crisisGLAXOSMITHKLINE15,920-0,62 %Sanofi shares a little firmer: Sanofi-GSK's COVID-19 vaccine will soon enter phase IIIThe COVID-19 vaccine developed by Sanofi together with GlaxoSmithKline has achieved positive results in the clinical phase II study and will be in the approval-relevant phase in a few weeks ...
► Read articleSANOFI87,74-0,41 %JPMORGAN leaves SANOFI on 'Overweight'NEW YORK (dpa-AFX Analyzer) - The US bank JPMorgan has left the classification for Sanofi after new study data for the treatment of multiple sclerosis at "Overweight" with a price target of 93 euros ....
► Read articleHALO COLLECTIVE0,0590,00 %Halo Collective Inc. reports record first quarter resultsNot for distribution to U.S. intelligence or for distribution in the United States. Unless otherwise noted, all numbers are in USD. ...
► Read articleROCHE283,68-0,24 %Roche receives FDA approval for Covid test in asymptomatic peopleBasel (awp) - Roche's Cobas test is designed to help detect asymptomatic infections with the corona virus. In the USA, the SARS-CoV-2 test from the Basel pharmaceutical company was approved by the US ...
► Read articleCANOPY GROWTH18,954+1,03 %Canopy Growth Corporation: Canopy Growth to Report Fourth Quarter and Fiscal Year 2021 Financial Results on June 1, 2021SMITHS FALLS, ON, May 18, 2021 / PRNewswire / - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the fourth quarter and fiscal .. .
► Read articleASTRAZENECA94,50+0,27 %Family doctors' association wants more freedom for Astrazeneca first-vaccinated peopleBERLIN (dpa-AFX) - The German Association of General Practitioners advocates more freedom for those who have been vaccinated for the first time with the Astrazeneca corona vaccine. "Otherwise there is the dilemma: Either Astrazeneca will ...
► Read articleABBVIE96,10+0,73 %AbbVie-partnered Chinese biotech with first-in-class ambitions showcases early data on CD73 antibody